ليسوريد (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "ليسوريد" in Arabic language version.

refsWebsite

Global rank Arabic rank

15nih.gov

4^th place

6^th place

12doi.org

2^nd place

5^th place

6web.archive.org

1^st place

4wikidata.org

43^rd place

2^nd place

3semanticscholar.org

11^th place

86^th place

2ebi.ac.uk

5,849^th place

872^nd place

2worldcat.org

5^th place

4^th place

2google.com.eg

3,246^th place

65^th place

1chemspider.com

8,573^rd place

3,029^th place

1wiley.com

222^nd place

221^st place

1archive.org

6^th place

3^rd place

1harvard.edu

18^th place

33^rd place

1books.google.com

3^rd place

8^th place

1bocsci.com

low place

archive.org

Egan CT، Herrick-Davis K، Miller K، Glennon RA، Teitler M (أبريل 1998). "Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors". Psychopharmacology. ج. 136 ع. 4: 409–14. DOI:10.1007/s002130050585. PMID:9600588. S2CID:3021798.

bocsci.com

"CAS 19875-60-6 Lisuride maleate". www.bocsci.com (بالإنجليزية). Archived from the original on 2022-11-19. Retrieved 2022-11-16.

books.google.com

J. Elks (14 نوفمبر 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. ص. 747–. ISBN:978-1-4757-2085-3. مؤرشف من الأصل في 2022-06-17.

chemspider.com

Lisuride، QID:Q2311683

doi.org

Horowski, R.; Löschmann, P.-A. (1 Apr 2019). "Classical dopamine agonists". Journal of Neural Transmission (بالإنجليزية). 126 (4): 449–454. DOI:10.1007/s00702-019-01989-y. ISSN:1435-1463. Archived from the original on 2022-07-24.
"DA agonists - Ergot derivaties: Lisuride". Movement Disorders (بالإنجليزية). 17 (S4): S74–S78. 2002-07. DOI:10.1002/mds.5565. ISSN:0885-3185. Archived from the original on 2022-07-25. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ= (help)
Ramírez Rosas MB، Labruijere S، Villalón CM، Maassen Vandenbrink A (أغسطس 2013). "Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs". Expert Opin Pharmacother. ج. 14 ع. 12: 1599–610. DOI:10.1517/14656566.2013.806487. PMID:23815106. S2CID:22721405.
Villalón CM، VanDenBrink AM (2017). "The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments". Mini Rev Med Chem. ج. 17 ع. 11: 928–938. DOI:10.2174/1389557516666160728121050. PMID:27465216.
Clarke CE، Speller JM (2000). "Lisuride for levodopa-induced complications in Parkinson's disease". Cochrane Database Syst Rev ع. 2: CD001515. DOI:10.1002/14651858.CD001515. PMC:7025784. PMID:10796801.
Clarke CE، Speller JM (2000). "Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease". Cochrane Database Syst Rev ع. 2: CD001514. DOI:10.1002/14651858.CD001514. PMC:7028005. PMID:10796800.
Egan CT، Herrick-Davis K، Miller K، Glennon RA، Teitler M (أبريل 1998). "Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors". Psychopharmacology. ج. 136 ع. 4: 409–14. DOI:10.1007/s002130050585. PMID:9600588. S2CID:3021798.
Hofmann C، Penner U، Dorow R، Pertz HH، Jähnichen S، Horowski R، Latté KP، Palla D، Schurad B (2006). "Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis". Clin Neuropharmacol. ج. 29 ع. 2: 80–6. DOI:10.1097/00002826-200603000-00005. PMID:16614540. S2CID:33849447.
Bakker RA، Weiner DM، ter Laak T، Beuming T، Zuiderveld OP، Edelbroek M، Hacksell U، Timmerman H، Brann MR، Leurs R (مارس 2004). "8R-lisuride is a potent stereospecific histamine H1-receptor partial agonist". Mol Pharmacol. ج. 65 ع. 3: 538–49. DOI:10.1124/mol.65.3.538. PMID:14978232.
Moreno JL، Holloway T، Albizu L، Sealfon SC، González-Maeso J (2011). "Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists". Neurosci. Lett. ج. 493 ع. 3: 76–9. DOI:10.1016/j.neulet.2011.01.046. PMC:3064746. PMID:21276828.
González-Maeso J، Ang RL، Yuen T، وآخرون (2008). "Identification of a serotonin/glutamate receptor complex implicated in psychosis". Nature. ج. 452 ع. 7183: 93–7. Bibcode:2008Natur.452...93G. DOI:10.1038/nature06612. PMC:2743172. PMID:18297054.
Auriemma RS، Pirchio R، De Alcubierre D، Pivonello R، Colao A (2019). "Dopamine Agonists: From the 1970s to Today". Neuroendocrinology. ج. 109 ع. 1: 34–41. DOI:10.1159/000499470. PMID:30852578.

ebi.ac.uk

Lisuride، QID:Q6120337
LISURIDE، QID:Q6120337

google.com.eg

books.google.com.eg

J. (14 Nov 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies (بالإنجليزية). Springer. ISBN:978-1-4757-2085-3. Archived from the original on 2022-11-16.
Swiss Pharmaceutical (2000). Index Nominum 2000: International Drug Directory (بالإنجليزية). Taylor & Francis. ISBN:978-3-88763-075-1. Archived from the original on 2022-11-16.

harvard.edu

ui.adsabs.harvard.edu

González-Maeso J، Ang RL، Yuen T، وآخرون (2008). "Identification of a serotonin/glutamate receptor complex implicated in psychosis". Nature. ج. 452 ع. 7183: 93–7. Bibcode:2008Natur.452...93G. DOI:10.1038/nature06612. PMC:2743172. PMID:18297054.

nih.gov

pubmed.ncbi.nlm.nih.gov

Ramírez Rosas MB، Labruijere S، Villalón CM، Maassen Vandenbrink A (أغسطس 2013). "Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs". Expert Opin Pharmacother. ج. 14 ع. 12: 1599–610. DOI:10.1517/14656566.2013.806487. PMID:23815106. S2CID:22721405.
Villalón CM، VanDenBrink AM (2017). "The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments". Mini Rev Med Chem. ج. 17 ع. 11: 928–938. DOI:10.2174/1389557516666160728121050. PMID:27465216.
Clarke CE، Speller JM (2000). "Lisuride for levodopa-induced complications in Parkinson's disease". Cochrane Database Syst Rev ع. 2: CD001515. DOI:10.1002/14651858.CD001515. PMC:7025784. PMID:10796801.
Clarke CE، Speller JM (2000). "Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease". Cochrane Database Syst Rev ع. 2: CD001514. DOI:10.1002/14651858.CD001514. PMC:7028005. PMID:10796800.
Egan CT، Herrick-Davis K، Miller K، Glennon RA، Teitler M (أبريل 1998). "Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors". Psychopharmacology. ج. 136 ع. 4: 409–14. DOI:10.1007/s002130050585. PMID:9600588. S2CID:3021798.
Hofmann C، Penner U، Dorow R، Pertz HH، Jähnichen S، Horowski R، Latté KP، Palla D، Schurad B (2006). "Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis". Clin Neuropharmacol. ج. 29 ع. 2: 80–6. DOI:10.1097/00002826-200603000-00005. PMID:16614540. S2CID:33849447.
Bakker RA، Weiner DM، ter Laak T، Beuming T، Zuiderveld OP، Edelbroek M، Hacksell U، Timmerman H، Brann MR، Leurs R (مارس 2004). "8R-lisuride is a potent stereospecific histamine H1-receptor partial agonist". Mol Pharmacol. ج. 65 ع. 3: 538–49. DOI:10.1124/mol.65.3.538. PMID:14978232.
Moreno JL، Holloway T، Albizu L، Sealfon SC، González-Maeso J (2011). "Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists". Neurosci. Lett. ج. 493 ع. 3: 76–9. DOI:10.1016/j.neulet.2011.01.046. PMC:3064746. PMID:21276828.
González-Maeso J، Ang RL، Yuen T، وآخرون (2008). "Identification of a serotonin/glutamate receptor complex implicated in psychosis". Nature. ج. 452 ع. 7183: 93–7. Bibcode:2008Natur.452...93G. DOI:10.1038/nature06612. PMC:2743172. PMID:18297054.
Auriemma RS، Pirchio R، De Alcubierre D، Pivonello R، Colao A (2019). "Dopamine Agonists: From the 1970s to Today". Neuroendocrinology. ج. 109 ع. 1: 34–41. DOI:10.1159/000499470. PMID:30852578.

ncbi.nlm.nih.gov

Clarke CE، Speller JM (2000). "Lisuride for levodopa-induced complications in Parkinson's disease". Cochrane Database Syst Rev ع. 2: CD001515. DOI:10.1002/14651858.CD001515. PMC:7025784. PMID:10796801.
Clarke CE، Speller JM (2000). "Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease". Cochrane Database Syst Rev ع. 2: CD001514. DOI:10.1002/14651858.CD001514. PMC:7028005. PMID:10796800.
Moreno JL، Holloway T، Albizu L، Sealfon SC، González-Maeso J (2011). "Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists". Neurosci. Lett. ج. 493 ع. 3: 76–9. DOI:10.1016/j.neulet.2011.01.046. PMC:3064746. PMID:21276828.
González-Maeso J، Ang RL، Yuen T، وآخرون (2008). "Identification of a serotonin/glutamate receptor complex implicated in psychosis". Nature. ج. 452 ع. 7183: 93–7. Bibcode:2008Natur.452...93G. DOI:10.1038/nature06612. PMC:2743172. PMID:18297054.

pubchem.ncbi.nlm.nih.gov

LISURIDE (بالإنجليزية), QID:Q278487

semanticscholar.org

api.semanticscholar.org

Ramírez Rosas MB، Labruijere S، Villalón CM، Maassen Vandenbrink A (أغسطس 2013). "Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs". Expert Opin Pharmacother. ج. 14 ع. 12: 1599–610. DOI:10.1517/14656566.2013.806487. PMID:23815106. S2CID:22721405.
Egan CT، Herrick-Davis K، Miller K، Glennon RA، Teitler M (أبريل 1998). "Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors". Psychopharmacology. ج. 136 ع. 4: 409–14. DOI:10.1007/s002130050585. PMID:9600588. S2CID:3021798.
Hofmann C، Penner U، Dorow R، Pertz HH، Jähnichen S، Horowski R، Latté KP، Palla D، Schurad B (2006). "Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis". Clin Neuropharmacol. ج. 29 ع. 2: 80–6. DOI:10.1097/00002826-200603000-00005. PMID:16614540. S2CID:33849447.

web.archive.org

Horowski, R.; Löschmann, P.-A. (1 Apr 2019). "Classical dopamine agonists". Journal of Neural Transmission (بالإنجليزية). 126 (4): 449–454. DOI:10.1007/s00702-019-01989-y. ISSN:1435-1463. Archived from the original on 2022-07-24.
"DA agonists - Ergot derivaties: Lisuride". Movement Disorders (بالإنجليزية). 17 (S4): S74–S78. 2002-07. DOI:10.1002/mds.5565. ISSN:0885-3185. Archived from the original on 2022-07-25. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ= (help)
J. Elks (14 نوفمبر 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. ص. 747–. ISBN:978-1-4757-2085-3. مؤرشف من الأصل في 2022-06-17.
J. (14 Nov 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies (بالإنجليزية). Springer. ISBN:978-1-4757-2085-3. Archived from the original on 2022-11-16.
Swiss Pharmaceutical (2000). Index Nominum 2000: International Drug Directory (بالإنجليزية). Taylor & Francis. ISBN:978-3-88763-075-1. Archived from the original on 2022-11-16.
"CAS 19875-60-6 Lisuride maleate". www.bocsci.com (بالإنجليزية). Archived from the original on 2022-11-19. Retrieved 2022-11-16.

wikidata.org

wiley.com

onlinelibrary.wiley.com

"DA agonists - Ergot derivaties: Lisuride". Movement Disorders (بالإنجليزية). 17 (S4): S74–S78. 2002-07. DOI:10.1002/mds.5565. ISSN:0885-3185. Archived from the original on 2022-07-25. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ= (help)

worldcat.org

Horowski, R.; Löschmann, P.-A. (1 Apr 2019). "Classical dopamine agonists". Journal of Neural Transmission (بالإنجليزية). 126 (4): 449–454. DOI:10.1007/s00702-019-01989-y. ISSN:1435-1463. Archived from the original on 2022-07-24.
"DA agonists - Ergot derivaties: Lisuride". Movement Disorders (بالإنجليزية). 17 (S4): S74–S78. 2002-07. DOI:10.1002/mds.5565. ISSN:0885-3185. Archived from the original on 2022-07-25. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ= (help)